Literature DB >> 18754747

In vitro and in vivo techniques to assess the performance of gastro-retentive drug delivery systems: a review.

Dhaivat C Parikh1, Avani F Amin.   

Abstract

BACKGROUND: Interest in gastro-retentive drug delivery systems (GRDDS) can be attributed to the desire for increased patient convenience (once daily dosing) and to increase the therapeutic index (reduced C(max), increased C(min)). A range of evaluation techniques for GRDDS exist for in vitro and in vivo evaluation.
OBJECTIVE: The aim of the present review is to describe the methodologies used for in vitro and in vivo evaluations of GRDDS.
METHODS: The proposed critical parameters for floating and swelling types of GRDDS are discussed. Modifications in dissolution testing and improved biorelevant testing methods are also described. The in vivo techniques for measuring gastro-retentive performance are also summarised.
CONCLUSION: The described methods can be used as assessment techniques for the evaluation and development of GRDDS. With these techniques, it is possible (with appropriate controls) to determine if a GRDDS provides hope for advantages of extended residence time in the stomach.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18754747     DOI: 10.1517/17425247.5.9.951

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  3 in total

1.  Novel gastroretentive sustained-release tablet of tacrolimus based on self-microemulsifying mixture: in vitro evaluation and in vivo bioavailability test.

Authors:  Yan-ping Wang; Yong Gan; Xin-xin Zhang
Journal:  Acta Pharmacol Sin       Date:  2011-09-19       Impact factor: 6.150

Review 2.  Gastro-retentive drug delivery systems: a recent update on clinical pertinence and drug delivery.

Authors:  Supratim Das; Sukhbir Kaur; Vineet Kumar Rai
Journal:  Drug Deliv Transl Res       Date:  2021-01-05       Impact factor: 4.617

Review 3.  In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms.

Authors:  Felix Schneider; Mirko Koziolek; Werner Weitschies
Journal:  Pharmaceutics       Date:  2019-08-16       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.